Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | QPCT | Q16769 | 1/20 | 0.47 |
| ▸ | PTPRS | Q13332 | 1/20 | 0.47 |
| ▸ | PRKDC | P78527 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.36 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12278195 | 0.74 | ALDH1A1 (0.59) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL7852356 | 0.74 | MAOB (0.61) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL29396201 | 0.71 | — | — | |
| SCHEMBL499141 | 0.71 | ALDH1A1 (0.53) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL9391119 | 0.69 | NPC1 (0.69) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL12277938 | 0.68 | ALDH1A1 (0.46) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL12278656 | 0.68 | NPC1 (0.46) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| Benzene SCHEMBL28071373 | 0.66 | L3MBTL1 (0.44) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL12278968 | 0.66 | ALDH1A1 (0.50) | ALDH1A1NPC1RAB9ALMNACASP3 | |
| SCHEMBL11651501 | 0.66 | QPCT (0.75) | ALDH1A1NPC1RAB9ALMNACASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119782065-A | Automatic integrated test and intelligent diagnosis system and method for computer main board | 深圳市华南三弦科技有限公司 | 2025-04-08 | — | — | CN | claimed |
| CN-118990482-A | Waist exoskeleton robot self-adaptive power-assisted control method | 南京理工大学 | 2024-11-22 | — | — | CN | claimed |
| CN-118534946-B | Dealcoholization flow control system and dealcoholization flow control method of dealcoholization tower based on esterification reaction | 山东长兴塑料助剂股份有限公司 | 2024-10-25 | — | — | CN | claimed |
| CN-118838388-A | Four-foot robot vision motion control method based on forward kinematics | 天津大学 | 2024-10-25 | — | — | CN | claimed |
| CN-114387129-A | Comprehensive energy scheduling method, device, equipment and medium considering natural gas pipe network | 国网江苏省电力有限公司扬州供电分公司 | 2022-04-22 | — | — | CN | claimed |
| CN-122043425-A | FMCW laser ranging light source spectrum degradation inhibition method based on strategy on-line deployment | 电子科技大学长三角研究院(衢州) | 2026-05-15 | — | — | CN | disclosed |
| US-20260094044-A1 | METHODS FOR MITIGATION AND FOR CHARACTERIZATION OF LOGICAL ERRORS IN ERROR CORRECTED QUANTUM PROCESSORS | QEDMA QUANTUM COMPUTING LTD (IL) | 2026-04-02 | — | — | US | disclosed |
| EP-4708157-A1 | METHODS FOR MITIGATION AND FOR CHARACTERIZATION OF LOGICAL ERRORS IN ERROR CORRECTED QUANTUM PROCESSORS | QEDMA Quantum Computing LTD (IL) | 2026-03-11 | — | — | EP | disclosed |
| US-20260042861-A1 | FORMULATIONS OF ANTI-CD38 ANTIBODIES FOR SUBCUTANEOUS ADMINISTRATION | SANOFI AVENTIS US LLC (US) | 2026-02-12 | — | — | US | disclosed |
| CN-120156236-A | Suspension control method, device, equipment and medium | 赛力斯汽车有限公司 | 2025-06-17 | — | — | CN | disclosed |
| EP-4559485-A2 | LIQUID ANTIBODY FORMULATION | ICHNOS SCIENCES S.A. (CH) | 2025-05-28 | — | — | EP | disclosed |
| CN-120043365-A | Intelligent control method, system and equipment for kiln atmosphere | 广东欧文莱陶瓷有限公司 | 2025-05-27 | — | — | CN | disclosed |
| WO-2022207374-A1 | METHOD FOR TESTING A MEASURING SYSTEM, AND TEST SYSTEM | iSyst Intelligente Systeme GmbH (DE) | 2022-10-06 | — | — | WO | disclosed |
| CN-115135302-A | IgG TGF beta RII fusion protein compositions | 阿雷斯贸易股份有限公司 | 2022-09-30 | — | — | CN | disclosed |
| US-20220298475-A1 | A CHEMOENZYMATIC METHOD FOR THE DETECTION OF CELL-CELL PROXIMITY INTERACTION AND ISOLATION OF TUMOR-SPECIFIC ANTIGEN REACTIVE T CELLS FOR IMMUNE THERAPY | THE SCRIPPS RESEARCH INSTITUTE | 2022-09-22 | — | — | US | disclosed |
| CN-114576230-A | Hydraulic loading device | 安徽建筑大学 | 2022-06-03 | — | — | CN | disclosed |
| US-11332535-B2 | Anti-CD123 antibodies and conjugates and derivatives thereof | IMMUNOGEN, INC. (US) | 2022-05-17 | — | — | US | disclosed |
| CN-114462684-A | Wind speed multipoint synchronous prediction method for coupling numerical weather forecast and measured data | 东南大学 | 2022-05-10 | — | — | CN | disclosed |
| CN-114387129-A | Comprehensive energy scheduling method, device, equipment and medium considering natural gas pipe network | 国网江苏省电力有限公司扬州供电分公司 | 2022-04-22 | — | — | CN | disclosed |
| EP-3977121-A1 | A CHEMOENZYMATIC METHOD FOR THE DETECTION OF CELL-CELL PROXIMITY INTERACTION AND ISOLATION OF TUMOR-SPECIFIC ANTIGEN REACTIVE T CELLS FOR IMMUNE THERAPY | The Scripps Research Institute (US) | 2022-04-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042861-A1 | FORMULATIONS OF ANTI-CD38 ANTIBODIES FOR SUBCUTANEOUS ADMINISTRATION | CD38, MUC1, CD209 | ALDH1A1 4272/4885NPC1 4681/4885RAB9A 1145/4885 |
| US-11332535-B2 | Anti-CD123 antibodies and conjugates and derivatives thereof | IL23R, CD22, IL2RA | ALDH1A1 1167/4885NPC1 1680/4885RAB9A 1040/4885 |
| US-20260094044-A1 | METHODS FOR MITIGATION AND FOR CHARACTERIZATION OF LOGICAL ERRORS IN ERROR CORRECTED QUANTUM PROCESSORS | GCLC, WRN, CUL1 | ALDH1A1 4379/4885NPC1 3864/4885RAB9A 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.